Screening of compounds for antimicrosporidial activity in vitro

Folia Parasitologica

Volumn 45, Issue 2, 1998, Pages 129-139

  Didier, Elizabeth S ^a   Maddry, Joseph A ^b   Kwong, Cecil D ^b   Green, Linda C ^a   Snowden, Karen F ^c   Shadduck, John A ^d  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^b SOUTHERN RESEARCH INSTITUTE   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

^d HESKA CORPORATION   (United States)

Author keywords

Chemotherapy; Microsporidia; Opportunistic protozoa

Indexed keywords

ANIMALIA; ENCEPHALITOZOON INTESTINALIS; MICROSPORIDIA; NOSEMA; ORYCTOLAGUS CUNICULUS; PROTOZOA; VITTAFORMA CORNEAE;

EID: 0031872536     PISSN: 00155683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. AARONS E., WOODROW D., HOLLISTER W.S., CANNING E.U., FRANCIS N., GAZZARD B.G. 1994: Reversible renal failure caused by a microsporidian infection. AIDS 8: 1119-1121.
2. ARMSTRONG E. 1976: Fumidil B and benomyl: chemical control of Nosema kingi in Drosophila willistoni. J. Invert. Pathol. 27: 363-366.
3. BEAUVAIS B., SARFATI C., CHALLIER S., DEROUIN F. 1994: In vitro model to assess effect of antimicrobial agents on Encephalitozoon cuniculi. Antimicrob. Agents Chemother. 38: 2440-2448.
4. BIGLIARDI E., SELMI M.G., LUPETTI P., CORONA S., GATTI S., SCAGLIA M., SACCHI L. 1996: Microsporidian spore wall: ultrastructural findings on Encephalitozoon hellem exospore. J. Euk. Microbiol. 43: 181-186.
5. BLAGBURN B.L., HENDRIX C.M., VAUGHAN J.L., LINDSAY D.S., BARNETT S.H. 1995: Efficacy of lufenuron against developmental stages of fleas (Ctenocephalides felis felis) in dogs housed in simulated home environments. Am. J. Vet. Res. 56:464-467.
6. BLAGBURN B.L., VAUGHAN J.L., LINDSAY D.S., TEBBITT G.L. 1994: Efficacy dosage titration of lufenuron against developmental stages of fleas (Ctenocephalides felis felis) in cats. Am. J. Vet. Res. 55: 98-101.
7. BLANSHARD C., ELLIS D.S., DOWELL S.P., TOVEY G., GAZZARD B.G. 1993: Electron microscopic changes in Enterocytozoon bieneusi following treatment with albendazole. J. Clin. Pathol. 46: 898-902.
8. BLANSHARD C., ELLIS D.S., TOVEY D.G., DOWELL S., GAZZARD B.G. 1992: Treatment of intestinal microsporidiosis with albendazole in patients with AIDS. AIDS 6: 311-313.
9. CALI A., KOTLER D.P., ORENSTEIN J.M. 1993: Septata intestinalis, N. G., N. Sp., an intestinal microsporidian associated with chronic diarrhea and dissemination in AIDS patients. J. Euk. Microbiol. 40: 101-112.
10. CANNING E.U., HOLLISTER W.S. 1992: Human infections with microsporidia. Rev. Med. Microbiol. 3: 35-42.
11. DAVIS R.M., FONT R.L., KEISLER M.S., SHADDUCK J.A. 1990: Corneal microsporidiosis. A case report including ultrastructural observations. Ophthalmology. 97: 953-957.
12. DEGROOTE M.A., VISVESVARA G.S., WILSON M.L., PIENIAZEK N.J., SLEMENDA S.B., DASILVA A.J., LEITCH G.J., BRYAN R.T., REVES R. 1995: Polymerase chain reaction and culture confirmation of disseminated Encephalitozoon cuniculi in a patient with AIDS. Successful treatment with albendazole. J. Infect. Dis. 171: 1375-1378.
13. DESPORTES I., LE CHARPENTIER Y., GALIAN A., BERNARD F., COCHAND-PRIOLLET B., LAVERGNE A., RAVISSE P., MODIGLIANI R. 1985: Occurrence of a new microsporidian, Enterocytozoon bieneusi n. g., n. sp., in the enterocytes of a human patient with AIDS. J. Protozool. 32: 250-254.
14. DIDIER E.S. 1995: Reactive nitrogen intermediates implicated in the inhibition of Encephalitozoon cuniculi (phylum Microspora) replication in murine peritoneal macrophages. Parasite Immunol. 17: 405-412.
15. DIDIER, E.S. 1997: Effects of albendazole, fumagillin, and TNP-470 on microsporidial replication in vitro. Antimicrob. Agents Chemother. 41: 1541-1546.
16. DIDIER E.S., DIDIER P.J., FRIEDBERG D.N., STENSON S.A., ORENSTEIN J.M., YEE R.W., TIO F.O., DAVIS R.M., VOSSBRINCK C., MILLICHAMP N., SHADDUCK J.A. 1991: Isolation and characterization of a new microsporidian, Encephalitozoon hellem (n. sp.) from three AIDS patients with keratoconjunctivitis. J. Infect. Dis. 163: 617-621.
17. DIDIER E.S., ROGERS L.B., BRUSH A.D., WONG S., BERTUCCI D.C. 1996a: Diagnosis of disseminated microsporidian Encephalitozoon hellem infection by PCR-Southern analysis and successful treatment with albendazole and fumagillin. J. Clin. Microbiol. 34: 947-952.
18. DIDIER E.S., ROGERS L.B., ORENSTEIN J.M., BAKER M.D., VOSSBRINCK C.R., VAN GOOL T., HARTSKEERL R., SOAVE R., BEAUDET L.M. 1996b: Characterization of Encephalitozoon (Septata) intestinalis isolates cultured from nasal mucosa and bronchoalveolar lavage fluids of two AIDS patients. J. Euk. Microbiol. 43: 34-43.
19. DIDIER E.S., SNOWDEN K.F., SHADDUCK J.A. 1998: Biology of microsporidian species infecting mammals. Adv. Parasitol. (in press).
20. DIDIER E.S., VARNER P.W., DIDIER P.J., ALDRAS A.M., MILLICHAMP N.J., MURPHEY-CORB M., BOHM R., SHADDUCK J.A. 1994: Experimental microsporidiosis in immunocompetent and immunodeficient mice and monkeys. Folia Parasitol 41: 1-11.
21. DIESENHOUSE M.C., WILSON L.A., CORRENT G.F., VISVESVERA G.S., GROSSNIKLAUS H.E., BRYAN R.T. 1993: Treatment of microsporidial kerato-conjunctivitis with topical fumagillin. Am. J. Ophthalmol. 115: 293-298.
22. DIETERICH D.T., LEW E., KOTLER D.P., POLES M., ORENSTEIN J.M. 1994: Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS. J. Inf. Dis. 169: 178-183.
23. DORE G.J., MARRIOTT D.J., HING M.C., HARKNESS J.L., FIELD A.S. 1995: Disseminated microsporidiosis due to Septata intestinalis is in nine patients infected with the human immunodeficiency virus: response to therapy with albendazole. Clin. Infect. Dis. 21: 70-76.
24. DUBREUIL L., HOUCKE, I., MOUTON, Y., ROSSIGNOL, J.F. 1996: In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms. Antimicrob. Agents Chemother. 40: 2266-2270.
25. FRAMM S.R., SOAVE R. 1997: Agents of diarrhea. Med. Clin. N. Am. 81: 427-447.
26. FRANC M., CADIERGUES M.C. 1997: Use of injectable lufenuron for treatment of infestations of Ctenocephalides felis in cats. Am. J. Vet. Res. 58: 140-142.
27. FRANSSEN F.F.J., LUMEIJ J.T., VAN KNAPEN F. 1995: Susceptibility of Encephalitozoon cuniculi to several drugs in vitro. Antimicrob. Agents Chemother. 39: 1265-1268.
28. FRANZEN C., FAETKENHEUER G., SALZBERGER B., MUELLER A., MAHRLE G., DIEHL V., SCHRAPPE M. 1994: Intestinal microsporidiosis in patients with acquired immunodeficiency syndrome - report of three more German cases. Infection 22: 417-419.
29. GARVEY M.J., AMBROSE P.G., ULMER J.L. 1995: Topical fumagillin in the treatment of microsporidial keratoconjunctivitis in AIDS. Ann. Pharmacother. 29: 872-874.
30. GHOSH A.K., BHATTACHARYYA F.K., GHOSH D.K. 1985: Leishmania donovani: amastigote inhibition and mode of action of berberine. Exp. Parasitol. 60: 404-413.
31. HARTSKEERL R.A., VAN GOOL T., SCHUITEMA A.R.J., DIDIER E.S., TERPSTRA W.J. 1995: Genetic and immunological characterization of the microsporidian Septata intestinalis is Cali, Kotler, and Orenstein, 1993: reclassification to Encephalitozoon intestinalis. Parasitology 110: 277-285.
32. HARTWIG A., PRZELECKA A. 1971: Nucleic acids in intestine of Apis mellifica infected with Nosema apis and treated with fumagillin DCH. Cytochemical and autoradiographic studies. J. Invertebr. Pathol. 18: 331-336.
33. HE Q., LEITCH G.J., VISVESVARA G.S., WALLACE S. 1996: Effects of nifedipine, metronidazole, and nitric oxide donors on spore germination and cell culture infection of the microsporidia, Encephalitozoon hellem and Encephalitozoon intestinalis. Antimicrob. Agents Chemother. 40: 179-185.
34. HINK W.F., ZAKSON M., BARNETT S. 1994: Evaluation of a single oral dose of lufenuron to control flea infestations in dogs. Am. J. Vet. Res. 55: 822-844.
35. INGBER D., FUJITA T., KISHIMOTO S., SUDO K., KANAMARU T., BREM H., FOLKMAN J. 1990: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348: 555-557.
36. JAMES S.L. 1995: Role of nitric oxide in parasitic infections. Microbiol. Rev. 29: 533-547.
37. JOSTE N.E., RICH J.D., BUSAM K.J., SCHWARTZ D.A. 1996: Autopsy verification of Encephalitozoon intestinalis (microsporidiosis) eradication following albendazole therapy. Arch. Pathol. Lab. Med. 120: 199-203.
38. KANEDA Y., TANAKA T., SAW T. 1990: Effects of berberine, a plant alkaloid, on the growth of anaerobic protozoa in axenic culture. Tokai. J. Exp. Clin. Med. 15: 417-423.
39. KELKAR R., SASTRY P.S., KULKARNI S.S., SAIKIA T.K., PARIKH P.M., ADVANI S.H. 1997: Pulmonary microsporidial infection in a patient with CML undergoing allogeneic marrow transplant. Bone Mar. Transplant. 19: 179-182.
40. KETZNELSON H., JAMIESON C.A. 1952: Control of Nosema disease of honey bees with fumagillin. Science 115:70.
41. KILLOUGH J.H., MAGILL G.B., SMITH R.C. 1952: The treatment of amebiasis with fumagillin. Science 115: 71-72.
42. KUSAKA M., SUDO K., FUJITA T., MARUE S., ITOH F., INGBER D., FOLKMAN J. 1991: Potent antiangiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem. Biophys. Res. Commun. 174: 1070-1076.
43. LACEY E. 1985: The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drug resistance to benzimidazoles. Int. J. Parasitol. 18: 885-936.
44. LOWDER C.Y., MCMAHON J.T., MEISLER D.M., DODDS E.M., CALABRESE L.H., DIDIER E.S., CALI A. 1996: Microsporidial keratoconjunctivitis cause by Septata intestinalis in a patient with acquired immunodeficiency syndrome. Am. J. Ophthalmol. 121:715-717.
45. MCCOWEN M.C., CALLENDER M.E., LAWLES J.F., Jr. 1951: Fumagillin (H-3), a new antibiotic with amebicidal properties. Science 113: 202-203.
46. MCDEVITT J.T., SCHNEIDER D.M., KATIYAR S.K., EDLIND T.D. 1996: Berberine: a candidate for the treatment of diarrhea in AIDS patients. Intersci. Conf. Antimicrob. Agents Chemother. F172: 130.
47. MERCK INDEX 1996: An Encyclopedia of Chemicals, Drugs, and Biologicals. 12th Edition. Merck & Co., Inc., Whitehouse Station, NJ, USA, 1741 pp.
48. MOLINA J.M., GOGUEL J., SARFATI C., CHASTANG C.I., DESPORTES I., MICHIELS J.F., MASLO C., KATLAMA C., COTTE L., LEPORT C., RAFFI F., DEROUIN F., MODAI J. 1997: Drug screening for the treatment of Enterocytozoon bieneusi infections in patients with HIV-infections. 4th Conf. Retrov. Oppor. Infec., Abstract No. 687: 191.
49. MOSSMAN T.R., FONG T.A.T. 1989: Specific assays for cytokine production by T cells. J. Immunol. Meth. 116: 151-158.
50. MURPHY J.R., FRIEDMANN J.C. 1985: Pre-clinical toxicology of nitazoxanide - a new antiparasitic compound. J. Appl. Toxicol. 5:49-52.
51. NISHIDA Y., HAGA C., ODA K., HAYAMA T. 1995: Disinfestation of experimentally infested cat fleas, Ctenocephalides felis, on cats and dogs by oral lufenuron. J. Vet. Med. Sci. 57: 655-658.
52. ORENSTEIN J.M. 1991: Microsporidiosis in the acquired immunodeficiency syndrome. J. Parasitol. 77: 843-864.
53. ORENSTEIN J.M., GAETZ H.P., YACHNIS AT., FRANKEL S.S., MERTENS R.B., DIDIER E.S. 1997: Disseminated microsporidiosis in AIDS: arc any organs spared? AIDS 11:385-386.
54. PLUDA J.M., WYVILL K., LIETZAU J., FIGG D., SAVILLE M.W., NGUYEN B.Y., FOLI A., BAILEY J., COOPER M., BRODER S., YARCHOAN R. 1993: A phase I trial of TNP-470 (AGM-1470) administered to patients with HIV-associated Kaposi's sarcoma (KS). First Nat. Conf. Hum. Retrovir. Relat. Infect. No. 61.
55. RABODONIRINA M., BERTOCCHI M., DESPORTESLIVAGE I., COTTE L., LEVREY H., PIENS M.A., MONNERET G., CELARD M., MORNEX J.F., MOJON M. 1996: Enterocytozoon bieneusi as a cause of chronic diarrhea in a heart-lung transplant recipient who was seronegative for human immunodeficiency virus. Clin. Infect. Dis. 23: 114-117.
56. ROSBERGER D.F., SERAREVIC O.N., ERLANDSON R.A., BRYAN R.T., SCHWARTZ D.A., VISVESVARA G.S. 1993: Successful treatment of microsporidial keratoconjunctivitis with topical fumagillin in a patient with AIDS. Cornea 12: 261-265.
57. ROSSIGNOL J.F., MAISONNEUVE H. 1984: Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana infections. Am. J. Trop. Med. Hyg. 33: 511-512.
58. SAX P.E., RICH J.D., PIECIAK W.S., TRNKA Y.M. 1995: Intestinal microsporidiosis occurring in a liver transplant recipient. Transplantation 60: 617-618.
59. SCHILLER L.R. 1995: Review article: anti-diarrhoeal pharmacology and therapeutics. Aliment Pharmacol. Ther. 9: 87-106.
60. SCHMIDT E.G., SHADDUCK J.A. 1984: Mechanisms of resistance to the intracellular protozoan parasite, Encephalitozoon cuniculi, in mice. J. Immunol. 133: 2712-2719.
61. SHADDUCK J.A. 1980: Effect of fumagillin in on in vitro multiplication of Encephalitozoon cuniculi. J. Protozool. 27: 202-208.
62. SHADDUCK J.A., MECCOLI R.A., DAVIS R., FONT R.L. 1990: First isolation of a microsporidian from a human patient. J. Infect. Dis. 162: 773-776.
63. SHAH G.K., PFISTER D., PROBST L.E., FERRIERI P., HOLLAND E. 1995: Diagnosis of microsporidial keratitis by confocal microscopy and the chromatrope stain. Am. J. Ophthalmol. 121: 89-91.
64. SILVEIRA H., CANNING E.U. 1995: Vittaforma corneae, N. Comb. for the human microsporidium Nosema corneum Shadduck, Meccoli, Davis & Font, 1990, based on its ultrastructure in the liver of experimentally infected athymic mice. J. Euk. Microbiol. 42: 158-165.
65. SMITH R.D., PAUL A.J., KITRON U.D., PHILIP J.R., BARNETT S., PIEL M.J., NESS R.W., EVILSIZER M. 1996: Impact of an orally administered insect growth regulator (lufenuron) on flea infestations of dogs in a controlled simulated home environment. Am. J. Vet. Res. 57: 502-504.
66. SOBOTTKA I. ALBRECHT H., SCHAEFER H., SCHOTTELIUS J., VISVESVARA G.S., LAUFS R., SCHWARTZ D.A. 1995: Disseminated Encephalitozoon (Septata) intestinalis infection in a patient with AIDS: novel diagnostic approaches and autopsy-confirmed parasitological cure following treatment with albendazole. J. Clin. Microbiol. 33: 2948-2952.
67. TSUJIMOTO H., HAGIWARA A., OSAKI K., OHYAMA T., SAKAKIBARA T., SAKUYAMA A., OHGAKI M., IMANISHI T., WATANABE N., YAMAZAKI J., SHIRASU M., SAKAKURA C., SHIMOTSUMA M., TAKAHASHI T. 1995: Therapeutic effects of the angiogenesis inhibitor TNP-470 against carcinomatous peritonitis in mice. Anti-Cancer Drugs 6:438-442.
68. VÁVRA J., DAHBIOVÁ R., HOLLISTER W.S., CANNING E.U. 1993: Staining of microsporidian spores by optical brighteners with remarks on the use of brighteners for the diagnosis of AIDS associated human microsporidioses. Folia Parasitol 40: 267-272.
69. WANKE C.A., BHALLA M., MATTIA A.R., HELLER H.M. 1993: Case records of the Massachusetts General Hospital (Case report 51-1993). N. Eng. J. Med. 329: 1946-1954.
70. WEBER R., BRYAN R.T., SCHWARTZ D.A., OWEN R.I. 1994a: Human microsporidial infections. Clin. Microbiol. Rev. 7: 426-461.
71. WEBER R., SAUER B., SPYCHER M.A., DEPLAZES P., KELLER R., AMMANN R., BRINER J., LUETHY R. 1994b: Detection of Septata intestinalis in stool specimens and coprodiagnostic monitoring of successful treatment with albendazole. Clin. Infect. Dis. 19: 342-345.
72. WILKINS J.H., JOSHI N., MARGOLIS T.P., CEVALLOS V., DAWSON C.R. 1994: Microsporidial kerato-conjunctivitis treated successfully with a short course of fumagillin. Eye 8: 703-704.
73. YAMAOKA M., YAMAMOTO T., IKEYAMA S., SUDO K., FUJITA T. 1993a: Angiogenesis inhibitor TNP-47 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines. Cancer Res. 53: 5233-5236.
74. YAMAOKA M., YAMAMOTO T., MASAKI T., IKEYAMA S., SUDO K., FUJITA T. 1993b: Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)-fumagillol (TNP-470; AGM-1470). Cancer Res. 53: 4262-4267.
75. YANAI S. H., OKADA S.H., SAITO K., KUGE Y., MISAKI M., OGAWA Y., TOGUCHI H. 1995: Antitumor effect of arterial administration of a medium-chain triglyceride solution of an angiogenesis inhibitor, TNP-470 in rabbits bearing VX-2 carcinoma. Pharm. Res. 12: 653-657.
76. YANASE T., TAMURA M., FUJITA K., KODAMA S., TANAKA K. 1993: Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res. 53: 2566-2570.